Drug Profile
SC 107
Latest Information Update: 04 Jul 2000
Price :
$50
*
At a glance
- Originator Scotia Holdings [CEASED]
- Class Analgesics; Antirheumatics
- Mechanism of Action Prostaglandin synthase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Musculoskeletal pain; Pain; Rheumatic disorders
Most Recent Events
- 04 Jul 2000 Discontinued-Preclinical for Musculoskeletal pain in United Kingdom (Unknown route)
- 04 Jul 2000 Discontinued-Preclinical for Pain in United Kingdom (Unknown route)
- 04 Jul 2000 Discontinued-Preclinical for Rheumatic disorders in United Kingdom (Unknown route)